148 related articles for article (PubMed ID: 11877365)
21. Involvement of imidazoline-preferring receptors in regulation of sympathetic tone.
Sannajust F; Head GA
Am J Cardiol; 1994 Dec; 74(13):7A-19A. PubMed ID: 7998588
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of sympathoinhibition by imidazolines.
Szabo B; Urban R
Ann N Y Acad Sci; 1995 Jul; 763():552-65. PubMed ID: 7677373
[TBL] [Abstract][Full Text] [Related]
23. Rilmenidine-induced ocular hypotension: role of imidazoline1 and alpha 2 receptors.
Chu TC; Wong W; Gluchowski C; Hughes BW; Potter DE
Curr Eye Res; 1996 Sep; 15(9):943-50. PubMed ID: 8921215
[TBL] [Abstract][Full Text] [Related]
24. Imidazoline receptors. A new concept in central regulation of the arterial blood pressure.
Bousquet P; Feldman J; Tibirica E; Bricca G; Greney H; Dontenwill M; Stutzmann J; Belcourt A
Am J Hypertens; 1992 Apr; 5(4 Pt 2):47S-50S. PubMed ID: 1350728
[TBL] [Abstract][Full Text] [Related]
25. Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit.
Feldman J; Tibiriça E; Bricca G; Dontenwill M; Belcourt A; Bousquet P
Br J Pharmacol; 1990 Jul; 100(3):600-4. PubMed ID: 2390682
[TBL] [Abstract][Full Text] [Related]
26. Ethanol counteraction of I1-imidazoline but not alpha-2 adrenergic receptor-mediated reduction in vascular resistance in conscious spontaneously hypertensive rats.
El-Mas MM; Abdel-Rahman AA
J Pharmacol Exp Ther; 1999 Feb; 288(2):455-62. PubMed ID: 9918545
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild-type and D79N alpha2A-adrenoceptor transgenic mice.
Zhu QM; Lesnick JD; Jasper JR; MacLennan SJ; Dillon MP; Eglen RM; Blue DR
Br J Pharmacol; 1999 Mar; 126(6):1522-30. PubMed ID: 10217548
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of pyrrolinic isosteres of rilmenidine. Discovery of cis-/trans-dicyclopropylmethyl-(4,5-dimethyl-4,5-dihydro-3H-pyrrol-2-yl)-amine (LNP 509), an I1 imidazoline receptor selective ligand with hypotensive activity.
Schann S; Bruban V; Pompermayer K; Feldman J; Pfeiffer B; Renard P; Scalbert E; Bousquet P; Ehrhardt JD
J Med Chem; 2001 May; 44(10):1588-93. PubMed ID: 11334568
[TBL] [Abstract][Full Text] [Related]
29. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
Gargalidis-Moudanos C; Parini A
J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808
[TBL] [Abstract][Full Text] [Related]
30. Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area.
Gomez RE; Ernsberger P; Feinland G; Reis DJ
Eur J Pharmacol; 1991 Mar; 195(2):181-91. PubMed ID: 1651861
[TBL] [Abstract][Full Text] [Related]
31. I1 receptors, cardiovascular function, and metabolism.
Bousquet P
Am J Hypertens; 2001 Nov; 14(11 Pt 2):317S-321S. PubMed ID: 11721890
[TBL] [Abstract][Full Text] [Related]
32. alpha(2)-adrenergic receptors are not required for central anti-hypertensive action of moxonidine in mice.
Tolentino-Silva FP; Haxhiu MA; Waldbaum S; Dreshaj IA; Ernsberger P
Brain Res; 2000 Apr; 862(1-2):26-35. PubMed ID: 10799665
[TBL] [Abstract][Full Text] [Related]
33. Is the sympathoinhibitory effect of rilmenidine mediated by alpha-2 adrenoceptors or imidazoline receptors?
Urban R; Szabo B; Starke K
J Pharmacol Exp Ther; 1994 Aug; 270(2):572-8. PubMed ID: 7915315
[TBL] [Abstract][Full Text] [Related]
34. Participation of imidazoline receptors and alpha(2-)-adrenoceptors in the central hypotensive effects of imidazoline-like drugs.
Bousquet P; Bruban V; Schann S; Greney H; Ehrhardt JD; Dontenwill M; Feldman J
Ann N Y Acad Sci; 1999 Jun; 881():272-8. PubMed ID: 10415925
[TBL] [Abstract][Full Text] [Related]
35. Renal effects of infusion of rilmenidine and guanabenz in conscious dogs: contribution of peripheral and central nervous system alpha 2-adrenoceptors.
Evans RG; Anderson WP
Br J Pharmacol; 1995 Sep; 116(1):1557-70. PubMed ID: 8564219
[TBL] [Abstract][Full Text] [Related]
36. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits.
Chan CK; Sannajust F; Head GA
J Pharmacol Exp Ther; 1996 Feb; 276(2):411-20. PubMed ID: 8632304
[TBL] [Abstract][Full Text] [Related]
37. Differential modulation by estrogen of alpha2-adrenergic and I1-imidazoline receptor-mediated hypotension in female rats.
El-Mas MM; Abdel-Rahman AA
J Appl Physiol (1985); 2004 Oct; 97(4):1237-44. PubMed ID: 15145918
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular effects of clonidine-like drugs in pithed rabbits.
Pompermayer K; Salgado MC; Feldman J; Bousquet P
Hypertension; 1999 Oct; 34(4 Pt 2):1012-5. PubMed ID: 10523400
[TBL] [Abstract][Full Text] [Related]
39. Alpha(2A)-adrenergic versus imidazoline receptor controversy in rilmenidine's action: alpha(2A)-antagonism in humans versus alpha(2A)-agonism in rabbits.
Molderings GJ; Bonisch H; Bruss M; Gothert M
Ann N Y Acad Sci; 2003 Dec; 1009():279-82. PubMed ID: 15028600
[TBL] [Abstract][Full Text] [Related]
40. Species-specific pharmacological properties of human alpha(2A)-adrenoceptors.
Molderings GJ; Bönisch H; Brüss M; Likungu J; Göthert M
Hypertension; 2000 Sep; 36(3):405-10. PubMed ID: 10988273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
